Allogeneic hematopoietic cell transplantation in dyskeratosis congenita: Short and long- term outcome of 183 consecutive patients transplanted at EBMT centersFabiana Cacace, Antonio M. Risitano, Filomena Pierri et al.|Blood|2025Cited by 1
<scp>Eltrombopag</scp> Added to Standard Immunosuppressive Treatment as Front‐Line Therapy for Severe Aplastic Anemia: Long‐Term Outcomes of the Phase‐3 Randomized Superiority <scp>EBMT</scp> ‐ <scp>SAAWP RACE</scp> StudyAntonio M. Risitano, Ghulam J. Mufti, Sofie R. Terwel et al.|American Journal of Hematology|2026Cited by 0